Microbot Medical Files 8-K

TL;DR

Microbot Medical filed an 8-K on 10/31/24 with financial updates.

AI Summary

Microbot Medical Inc. filed an 8-K on October 31, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as STEMCELLS INC and CYTOTHERAPEUTICS INC/DE, is incorporated in Delaware and its principal executive offices are located in Braintree, MA.

Why It Matters

This filing provides an update on Microbot Medical Inc.'s regulatory disclosures and financial statements, which are important for investors to assess the company's current status.

Risk Assessment

Risk Level: low — This is a routine filing of financial statements and disclosures, not indicating any immediate operational or financial distress.

Key Players & Entities

• Microbot Medical Inc. (company) — Registrant
• STEMCELLS INC (company) — Former Company Name
• CYTOTHERAPEUTICS INC/DE (company) — Former Company Name
• October 31, 2024 (date) — Date of Report

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark

Filing Documents

• form8-k.htm (8-K) — 38KB
• ex99-1.htm (EX-99.1) — 28KB
• ex99-1_001.jpg (GRAPHIC) — 67KB
• ex99-1_002.jpg (GRAPHIC) — 156KB
• ex99-1_003.jpg (GRAPHIC) — 117KB
• ex99-1_004.jpg (GRAPHIC) — 83KB
• ex99-1_005.jpg (GRAPHIC) — 67KB
• ex99-1_006.jpg (GRAPHIC) — 131KB
• ex99-1_007.jpg (GRAPHIC) — 113KB
• ex99-1_008.jpg (GRAPHIC) — 48KB
• ex99-1_009.jpg (GRAPHIC) — 132KB
• ex99-1_010.jpg (GRAPHIC) — 71KB
• ex99-1_011.jpg (GRAPHIC) — 109KB
• ex99-1_012.jpg (GRAPHIC) — 111KB
• ex99-1_013.jpg (GRAPHIC) — 96KB
• ex99-1_014.jpg (GRAPHIC) — 122KB
• ex99-1_015.jpg (GRAPHIC) — 72KB
• ex99-1_016.jpg (GRAPHIC) — 116KB
• ex99-1_017.jpg (GRAPHIC) — 63KB
• ex99-1_018.jpg (GRAPHIC) — 473KB
• ex99-1_019.jpg (GRAPHIC) — 62KB
• 0001493152-24-043138.txt ( ) — 3283KB
• mbot-20241031.xsd (EX-101.SCH) — 3KB
• mbot-20241031_lab.xml (EX-101.LAB) — 33KB
• mbot-20241031_pre.xml (EX-101.PRE) — 24KB
• form8-k_htm.xml (XML) — 4KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On October 31, 2024, Microbot Medical Inc. (the "Company") released updated presentation materials, which are expected to be posted on its website on or about October 31, 2024. The presentation materials will be accessed via the Investors' section, under IR Resources' and then Additional Resources,' of the Company's website at www.microbotmedical.com. The Company is not undertaking to update these presentation materials. The presentation materials are also furnished as Exhibit 99.1 to this Current Report on Form 8-K and are incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This report will not be deemed an admission as to the materiality of any information herein (including Exhibit 99.1).

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Presentation Materials 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: October 31, 2024

View Full Filing

View this 8-K filing on SEC EDGAR